Search results

An updated edition of the June 2, 2026 article.The streaming-content industry is entering a new phase. Subscriber growth and exclusive programming still matter, but the competitive focus has

D.R. Horton, Inc. DHI presents a restrained investment case rather than a clean buy signal. The homebuilder is still producing cash, supporting shareholders and managing inventory carefully.The

Interactive Brokers Group’s IBKR second-quarter 2026 adjusted earnings per share of 69 cents surpassed the Zacks Consensus Estimate of 64 cents. The bottom line reflected a rise of 35.3% from the

East West Bancorp, Inc.’s EWBC  second-quarter 2026 earnings per share of $2.63 beat the Zacks Consensus Estimate of $2.61. Moreover, the bottom line increased 17.4% from the prior-year quarter’s

Hancock Whitney Corp.’s HWC  second-quarter 2026 earnings per share of $1.55 matched the Zacks Consensus Estimate. The bottom line rose 17.4% from the prior-year quarter.Results were supported by

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

SoundHound AI SOUN is strengthening its position as a leading provider of AI-powered restaurant automation, making 2026 an important year for the company. While SoundHound is still expanding beyond

Hasbro, Inc. HAS has a better growth story than it had earlier in the year, but the investment case is not one-sided. The company beat expectations, raised its fiscal 2026 outlook and has

Intuitive Surgical ISRG still offers investors a high-quality growth profile, but the case is not just about procedure gains.

The buy-or-wait debate depends on whether procedure growth, recurring

Investors might want to bet on Bioventus (BVS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of

Investors might want to bet on Travelers (TRV), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Wave Life Sciences (WVE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates

Investors might want to bet on Valvoline (VVV), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one

Investors might want to bet on Canadian Natural Resources (CNQ), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in